Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2025 ∙ Satyam, S. M. El-Tanani, M. Bairy, L. K. Rehman, A. Srivastava, A. Kenneth, J. M. Prem, S. M.
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2025 ∙ Jafari, Z. Kolb, B. E. Aiken, S. Wilson, S.
Updates on Auditory Outcomes of COVID-19 and Vaccine Side Effects: An Umbrella Review
All age groups Pregnant women COVID-19 Safety
Rating:
Not applicable
2025 ∙ Pan, H. Yu, Y. Li, X. Wang, M. Wen, C. Dai, Q. Huang, L.
Vaccination and rheumatoid arthritis: an updated systematic review and meta-analysis of data from 25,949,597 participants
All age groups Safety
Rating:
Low
2025 ∙ Li, Y. Liu, Z. Zhou, L. Li, R.
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis
Western Pacific China All age groups Economic aspects Acceptance
Rating:
Not applicable
2024 ∙ Nangsue, C. Srisurapanont, K. Sudjaritruk, T.
A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low
2024 ∙ Ewongwo, A. Sahor, A. F. Ngwa, W. Nwachukwu, C.
A guide to global access to HPV vaccination to all women in low- and middle-income countries; a minireview of innovation and equity
All age groups Low and Middle Income Countries Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
2024 ∙ Felsher, M. Shumet, M. Velicu, C. Chen, Y. T. Nowicka, K. Marzec, M. Skowronek, G. Pieniazek, I.
A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs
All age groups Human papillomavirus (HPV) Coverage
Rating:
Not applicable
2024 ∙ Lieberman, J. A. Chu, D. K. Ahmed, T. Dribin, T. E. Abrams, E. M. Anagnostou, A. Blumenthal, K. G. Boguniewicz, M. Chase, N. M. Golden, D. B. K. Hartog, N. L. Heimall, J. R. Ho, T. Lawrence, M. G. Khan, D. A. Minniear, T. D. Mustafa, S. S. Oppenheimer, J. J. Phillips, E. J. Ramsey, A. Rider, N. L. Schneider, L. Shaker, M. S. Spergel, J. M. Stone, C. A. Stukus, D. R. Wang, J. Greenhawt, M. J.
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology
All age groups Safety Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Wang, F. Gao, Y. Wagner, A. L. Lu, Y.
A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination
Newborn Children Adolescents Adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Liu, S. Durantini, M. R. Calabrese, C. Sanchez, F. Albarracin, D.
A systematic review and meta-analysis of strategies to promote vaccination uptake
All age groups Coverage
Rating:
Not applicable
Loading...